Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $75,474 - $92,427
-999 Reduced 23.49%
3,254 $295,000
Q3 2022

Nov 03, 2022

BUY
$74.61 - $87.26 $101,768 - $119,022
1,364 Added 47.21%
4,253 $324,000
Q2 2022

Jul 27, 2022

BUY
$80.52 - $93.75 $3,301 - $3,843
41 Added 1.44%
2,889 $244,000
Q1 2022

May 09, 2022

SELL
$80.11 - $90.62 $35,088 - $39,691
-438 Reduced 13.33%
2,848 $249,000
Q4 2021

Jan 27, 2022

SELL
$79.7 - $88.13 $14,106 - $15,599
-177 Reduced 5.11%
3,286 $287,000
Q3 2021

Oct 13, 2021

SELL
$81.78 - $95.14 $107,295 - $124,823
-1,312 Reduced 27.48%
3,463 $283,000
Q2 2021

Aug 10, 2021

SELL
$85.24 - $94.15 $68,959 - $76,167
-809 Reduced 14.49%
4,775 $435,000
Q1 2021

Apr 20, 2021

BUY
$83.5 - $98.47 $6,513 - $7,680
78 Added 1.42%
5,584 $477,000
Q4 2020

Feb 11, 2021

SELL
$78.07 - $94.43 $127,019 - $153,637
-1,627 Reduced 22.81%
5,506 $519,000
Q3 2020

Nov 09, 2020

BUY
$82.14 - $91.0 $148,262 - $164,255
1,805 Added 33.88%
7,133 $620,000
Q2 2020

Aug 07, 2020

SELL
$80.93 - $91.1 $54,708 - $61,583
-676 Reduced 11.26%
5,328 $468,000
Q1 2020

Apr 21, 2020

BUY
$70.67 - $99.01 $11,589 - $16,237
164 Added 2.81%
6,004 $494,000
Q4 2019

Jan 31, 2020

BUY
$84.35 - $95.37 $12,821 - $14,496
152 Added 2.67%
5,840 $554,000
Q3 2019

Nov 08, 2019

SELL
$85.54 - $94.26 $273,899 - $301,820
-3,202 Reduced 36.02%
5,688 $494,000
Q2 2019

Jul 30, 2019

SELL
$75.4 - $92.8 $693,680 - $853,760
-9,200 Reduced 50.86%
8,890 $812,000
Q1 2019

May 02, 2019

BUY
$75.32 - $86.15 $700,475 - $801,195
9,300 Added 105.8%
18,090 $1.74 Million
Q4 2018

Jan 24, 2019

BUY
$73.66 - $82.02 $647,471 - $720,955
8,790 New
8,790 $752,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Andesa Financial Management Inc. Portfolio

Follow Andesa Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andesa Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andesa Financial Management Inc. with notifications on news.